113342-32-8 Usage
Derivative of pyrazole and carboxylic acid
This compound is derived from two main structures, pyrazole and carboxylic acid, which contribute to its chemical properties and potential applications.
Chloro and methyl group
The presence of a chloro (-Cl) and a methyl (-CH3) group attached to the phenyl ring contributes to the compound's chemical reactivity and properties.
Pharmaceutical intermediate
1H-Pyrazole-3-carboxylic acid, 5-(4-chloro-3-methylphenyl)can be used as a building block or intermediate in the synthesis of more complex pharmaceutical compounds.
Organic synthesis
The compound can also be used as a reactant or intermediate in the synthesis of other organic compounds, contributing to the development of new chemical products.
Biological activity
Due to its structural features, 1H-Pyrazole-3-carboxylic acid, 5-(4-chloro-3-methylphenyl)may exhibit biological activity, which could be relevant for pharmaceutical applications.
Further research needed
More research is required to fully explore the potential uses of this compound in the pharmaceutical and chemical industries, including its potential applications and any potential side effects or limitations.
Check Digit Verification of cas no
The CAS Registry Mumber 113342-32-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,3,4 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 113342-32:
(8*1)+(7*1)+(6*3)+(5*3)+(4*4)+(3*2)+(2*3)+(1*2)=78
78 % 10 = 8
So 113342-32-8 is a valid CAS Registry Number.
113342-32-8Relevant articles and documents
Tritiation of the cannabinoid receptor antagonist SR144528 involving lithium aluminum tritide reduction; assessment of the kinetic isotope effect by 3H-NMR
Seltzman, Herbert H.,Foster, Matthew C.,Wyrick, Christopher D.,Burgess, Jason P.,Carroll, F. Ivy
, p. 589 - 596 (2007/10/03)
The cannabinoid receptor antagonist SR144528 was synthesized by an approach that enabled the incorporation of high specific activity tritium label while circumventing the lability of the target compound to catalytic hydrogenation. Lithium aluminum tritide
